news highlight

• 
  South Korean researchers develop task AI enabling robots to learn, execute everyday chores SEOUL, March 12 (AJP) - South Korean researchers have developed a robotic task artificial intelligence system capable of learning and carrying out routine household and workplace chores by observing human demonstrations, the state-run Korea Institute of Machinery & Materials (KIMM) said Thursday. The AI system, built by a team led by Kim Jeong-jung at KIMM's Department of AI Machinery, allows robots to acquire task skills from human demonstrations, replicate them in a virtua March 12, 2026
• 
  LG CNS strikes strategic partnership with Palantir to accelerate AI transformation push SEOUL, March 12 (AJP) - LG CNS, the IT services arm of South Korea's LG Group, signed a strategic partnership with U.S. artificial intelligence software firm Palantir Technologies, as the company moves to broaden its enterprise AI platform business. The agreement was signed ahead of Palantir's AIPCon event in the United States. LG CNS President and CEO Hyun Shin-gyoon and Palantir co-founder and CEO Alex Karp were among senior executives present at the signing ceremony on We March 12, 2026
• 
  Celltrion launches Remsima liquid formulation in Europe, wins Nordic tenders SEOUL, March 11 (AJP) - South Korean biosimilar giant Celltrion announced Wednesday it has launched a liquid formulation of its flagship infliximab treatment Remsima IV in Europe, securing government tender contracts in Denmark and Norway in an early push to tighten its grip on the continent's infliximab market. The new formulation, which received European Commission approval in November, is the world's only liquid version of intravenous infliximab. Available in 100 mg and 3 March 11, 2026
• 
  LG CNS invests in U.S. robotics firm Dexmate, broadening humanoid hardware lineup SEOUL, March 10 (AJP) - South Korean IT solutions provider LG CNS said it has made a strategic investment in Dexmate, a Silicon Valley-based robotics startup, marking the first such deal by a Korean company with the U.S. firm. The investment, announced Tuesday, was channeled through LG Technology Ventures, the conglomerate's corporate venture capital arm. Dexmate, founded by PhDs from MIT, UC San Diego and Carnegie Mellon University, manufactures humanoid robots whose hardwar March 10, 2026
• 
  Joint research team develops mRNA platform effective for aging and obesity SEOUL, March 10 (AJP) - A joint research team from the Korea Advanced Institute of Science and Technology (KAIST) and the Catholic University of Korea has developed a new mRNA platform designed to maintain high therapeutic efficacy in elderly and obese populations. The technology improves the production of therapeutic proteins by optimizing specific regulatory sequences within mRNA molecules, addressing a major limitation where current treatments lose effectiveness due to age or meta March 10, 2026
• 
  Go grandmaster urges shift to AI collaboration decade after AlphaGo match SEOUL, March 9 (AJP) - Former South Korean Go grandmaster Lee Se-dol returned to the site of his historic 2016 match against AlphaGo on Monday to advocate for a new era of cooperation between humans and artificial intelligence. Speaking during a press conference held at the Four Seasons Hotel in Seoul, the same location where he faced the Google DeepMind program 10 years ago, Lee reflected on how the perception of AI has evolved from a competitive threat to a collaborative tool. March 9, 2026
• 
  Joint research team identifies neural mechanism behind drug addiction relapse SEOUL, March 09 (AJP) - A joint research team from South Korea and the United States has identified a specific neural circuit in the brain that controls drug-seeking behavior. This discovery challenges the long-held belief that addiction relapse is caused by a general decline in willpower or a permanent loss of function in the prefrontal cortex. A team led by Professor Baek Se-bum of the Korea Advanced Institute of Science and Technology (KAIST) and Professor Lim Byung-kook of the Un March 9, 2026
• 
  Celltrion solidifies biosimilar dominance across key Asian markets SEOUL, March 09 (AJP) - Celltrion has tightened its grip on major Asian biosimilar markets, with several of its flagship products commanding leading market shares in Singapore, Hong Kong, Thailand and Malaysia, buoyed by an aggressive direct-sales push and a steady pipeline of new launches. Data from IQVIA showed that Celltrion's autoimmune treatment Remsima (infliximab) held the top prescription spot across all four markets as of the third quarter of 2025, capturing 93 percent March 9, 2026
• 
   Sookmyung Women's University researchers identify protein key to maintaining healthy muscle SEOUL, March 06 (AJP) - Professor Yang Young and Dr. Han So-ra from the Department of Biological Sciences and the Research Institute of Women's Health at Sookmyung Women's University have identified that CTRP1, a myokine produced in muscles, plays a critical role in maintaining healthy skeletal muscle. The research team found that CTRP1 regulates mitochondrial homeostasis in immature muscle cells to support normal muscle differentiation. This process induces the formation March 6, 2026